about
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersDrug Targets for Oxidative Podocyte Injury in Diabetic NephropathyNon-Proteinuric Diabetic NephropathyPerspectives on systems biology applications in diabetic kidney diseaseDe novo glomerular diseases after renal transplantationEffective Delivery of Endogenous Antioxidants Ameliorates Diabetic NephropathyMesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic NephropathyO-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cellsThe Genetic Landscape of Renal Complications in Type 1 Diabetes.Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.Is the time ripe for kidney tissue proteomics?Fenugreek Prevents the Development of STZ-Induced Diabetic Nephropathy in a Rat Model of Diabetes.Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.Antidiabetic effect of Sida cordata in alloxan induced diabetic ratsDiabetic kidney disease in children and adolescents.Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice.Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis.Proximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional study.Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.Nutrient sensing, autophagy, and diabetic nephropathy.Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes.Diabetes-related alterations in the enteric nervous system and its microenvironment.Naringenin ameliorates pathological changes in liver and kidney of diabetic mice: a preliminary study.Mouse Models of Diabetes, Obesity and Related Kidney Disease.Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.Can we target tubular damage to prevent renal function decline in diabetes?Glomerulopathy in the KK.Cg-A(y) /J mouse reflects the pathology of diabetic nephropathy.The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats.Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.A glimpse of various pathogenetic mechanisms of diabetic nephropathy.Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy.Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.Mice deficient in PAPP-A show resistance to the development of diabetic nephropathyConnective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?Diabetic nephropathy: Is it time yet for routine kidney biopsy?Improving microvascular outcomes in patients with diabetes through management of hypertension.
P2860
Q24644869-A6B13865-7F89-4986-B727-1A3B99C20706Q26769787-5D1A2885-DEB2-4C03-976C-B2D904C4C7CBQ26786923-53A25B99-8C16-41BD-9C59-EB8DAD5D44B3Q26823206-0F1DD3E6-1716-4A6D-91DD-06AB42AF68E5Q27005877-A8E7B966-2D77-4240-98CC-328F83924E8EQ27303768-8E327824-2E2F-41C3-A307-16729A3F3497Q28354224-72CED8AB-7808-4146-81BD-F21EDFA2FBCAQ28569862-BD001707-D120-44A4-97C8-3919CA282FA3Q30275890-DA281213-FA32-480D-97D2-714DDA1CECA1Q33761954-673D4EA0-63F4-4C1E-B6D7-217494AB949DQ33783045-B0248C68-A51F-4D80-B30B-F77AAF3A6DE5Q33825220-897AF630-62BA-4EC6-A6D9-67654895D3E8Q33888480-DBA7FA12-BDD7-4D66-800C-BC950B8A46AEQ33905101-88E9EC2A-337A-4617-9BC0-EF4268F7677AQ33917811-84D11DD2-BF67-43BC-B828-2E21AA111274Q33993986-1781A7F2-E303-4B9E-B205-BF822B6D5097Q34214578-C6205DFC-B8B3-46E8-A988-D4D786D0948AQ34367428-7C8720F6-E09C-4562-9FD6-E69E7D2BADD2Q34731321-7EF9AE21-9BB7-4701-AF57-B6C08A53B73BQ35421414-8E4EAF4A-ADB2-4935-983F-37E2CA2657D1Q35591301-5B7B3E07-ED58-47CB-829A-5B08946BD5B9Q35612372-CAB45A7F-AFAC-4508-A3EE-37D97A61D8DAQ35663915-FD4F8D37-EBE8-4647-AB85-1BFC09FA69E1Q35902228-315E08CE-3172-42E5-BB53-9E53B69F9F3DQ35988135-0BF6A693-0308-48BD-9321-4374FB333955Q35993515-474666D9-2D4D-4E6F-9E38-BC9624D6950CQ36118363-14D4A99F-44E6-450A-A07D-58956A29BACEQ36188834-45D86F6A-36C3-477B-A726-28B8AC403412Q36677752-823445B9-959C-45C5-A50C-5AE9DF5FB889Q36848587-347010EA-CC84-4B65-802B-26500158F299Q36880835-7C1A8E7D-B4A4-45C9-A5FB-9EC8E4EE2D68Q36891626-E9136210-AEAE-458A-A21A-149763B0AD0EQ36979205-8A7ADA3E-B393-4AA9-BCA5-D2D4774B4B87Q37066937-A22811FF-A1EB-4D70-994F-8786BD71E870Q37180781-FA0BEC8E-AB43-4E13-A4F8-7AC6D55AB2D7Q37280851-188D7A83-69E4-4843-92A3-EE0394EDCF0DQ37286585-AF7CA6E6-3863-46C4-8F37-15329BCF14AAQ37392107-F9498DC6-ECD9-4DFE-906C-A8FEBB5A6BB6Q37417746-E1DA1B49-343F-4584-BED4-A3C57F8CC897Q37427251-46C768BC-F561-4D6A-B858-A8732D7ADD84
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Histopathology of diabetic nephropathy
@en
type
label
Histopathology of diabetic nephropathy
@en
prefLabel
Histopathology of diabetic nephropathy
@en
P2860
P1476
Histopathology of diabetic nephropathy
@en
P2093
Michael Mauer
Paola Fioretto
P2860
P304
P356
10.1016/J.SEMNEPHROL.2007.01.012
P577
2007-03-01T00:00:00Z